XOMA Royalty (FRA:X0M1) OCF Margin %: 1,975.75% (As of Mar. 2026)

What is XOMA Royalty OCF Margin %?

XOMA Royalty FRA:X0M1 30 OCF Margin % is 1,975.75% as of Mar. 2026. GuruFocus rates FRA:X0M1 with a GF Score™ of 30/100 and a GF Value™ of €15.81 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 959 Biotechnology companies, XOMA Royalty ranks better than 98.33% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. XOMA Royalty's Cash Flow from Operations for the three months ended in Mar. 2026 was €5.30 Mil. XOMA Royalty's Revenue for the three months ended in Mar. 2026 was €0.27 Mil. Therefore, XOMA Royalty's OCF Margin % for the quarter that ended in Mar. 2026 was 1,975.75%.

As of today, XOMA Royalty's current OCF Yield % is 0.92%.

The historical rank and industry rank for XOMA Royalty's OCF Margin % or its related term are showing as below:

FRA:X0M1' s OCF Margin % Range Over the Past 10 Years
Min: -605.48 Med: -68.04 Max: 59.43
Current: 90.1

During the past 13 years, the highest OCF Margin % of XOMA Royalty was 59.43%. The lowest was -605.48%. And the median was -68.04%.

FRA:X0M1's OCF Margin % is ranked better than
98.33% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs FRA:X0M1: 90.10

XOMA Royalty OCF Margin % Related Terms

XOMA Royalty OCF Margin % Historical Data

* Premium members only.

The historical data trend for XOMA Royalty's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XOMA Royalty OCF Margin % Chart

XOMA Royalty Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

59.43

-213.71

-381.64

-134.52

24.62

XOMA Royalty Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															50.91	120.26	-55.63	-384.14	1,975.75

FRA:X0M1 vs EDIT, FDMT, KYTX: OCF Margin % Comparison

For the Biotechnology subindustry, XOMA Royalty's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XOMA Royalty OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XOMA Royalty's OCF Margin % distribution charts can be found below:

* The bar in red indicates where XOMA Royalty's OCF Margin % falls into.

Save Embed

30GF Score

XOMA Royalty Corp FRA:X0M1

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

XOMA Royalty OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

XOMA Royalty's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	2.452	/	9.958
	=	24.62 %

XOMA Royalty's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	5.295	/	0.268
	=	1,975.75 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of 1,975.75% mean?

XOMA Royalty (FRA:X0M1) has a OCF Margin % of 1,975.75% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on XOMA Royalty and its competitors. According to the industry distribution chart, XOMA Royalty ranks #16 out of 959 companies in the Biotechnology industry, placing it in the top 1.7%.

Is XOMA Royalty's OCF Margin % too high?

XOMA Royalty's current OCF Margin % is 1,975.75%. Based on the distribution chart, XOMA Royalty ranks #16 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, XOMA Royalty has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does XOMA Royalty's OCF Margin % compare to EDIT and FDMT?

According to the Biotechnology industry distribution chart, XOMA Royalty ranks #16 out of 959 companies for OCF Margin %. This places XOMA Royalty in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on XOMA Royalty and its competitors. XOMA Royalty's current OCF Margin % is 1,975.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is XOMA Royalty stock overvalued right now?

Based on GuruFocus' analysis, XOMA Royalty (FRA:X0M1) is currently considered Significantly Overvalued. The stock's GF Value™ is €15.81, compared to a current price of €35.20 — trading 122.6% above its estimated fair value. The current OCF Margin % is 1,975.75%. XOMA Royalty's overall GF Score™ is 30/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For XOMA Royalty (FRA:X0M1), the current OCF Margin % is 1,975.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is XOMA Royalty (FRA:X0M1) Overvalued in 2026?

Based on GuruFocus' analysis, XOMA Royalty stock appears to be overvalued. The current stock price of €35.20 is trading 122.6% above its estimated GF Value™ of €15.81. GuruFocus considers XOMA Royalty to be Significantly Overvalued.

Key valuation signals for FRA:X0M1:

OCF Margin %: 1,975.75%
GF Value™: €15.81 vs. price of €35.20 (122.6% above fair value)
GF Score™: 30/100 with 9 warning signs

No single metric tells the full story. See the FRA:X0M1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

XOMA Royalty Business Description

Industry Healthcare Biotechnology

Comparable Companies EDIT FDMT KYTX PRTA OVID ACHV CTNM AUTL ASMB MDXG VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges XOMAO.PFD:USA XOMAP.PFD:USA XOMA:USA 0M26:UK

Address 2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608

Website https://www.xoma.com

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.

30GF Score

Get the complete analysis for FRA:X0M1

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€35.20

Price

€15.81

GF Value

View FRA:X0M1 Analysis

See OCF Margin % data for all stocks →